1984 Volume 32 Issue Supplement2 Pages 404-407
Clinical efficacy of TA-058, a newly developed penicillin derivative, were evaluated in total 10 cases of patients, 4 cases with pneumonia, one with lung abscess, one with chronic bronchitis, one with cystitis, and 3 with secondary respiratory tract infection complicating lung cancer.
The clinical effects obtained were excellent in 3 patients, good in 2 patients, and fair in 2 patients. 3 patients could not be assessed clinically.
In bacteriological study, 2 strains of Haemophilus, 2 strains of P.aeruginosa were eradicated, 1 strain of K.oxytoca, 1 strain of E.cloacae were persisted.
Neither side effects nor adverse reactions on clinical laboratory findings attributable to the drug were observed.
